| ADMA Biologics, Inc. | Common | $1.1M | 0.5% | 60,200 SH | New |
| Agios Pharmaceutical, Inc. | Common | $490K | 0.2% | 18,000 SH | New |
| Alkermes PLC | Common | $2.7M | 1.2%Prev: 0.2% | 95,000 SH | Increased+75,700 SH |
| AllianceBernstein Holding L.P. | Common | $1.8M | 0.9%Prev: 0.7% | 48,000 SH | Increased |
| Alphabet Inc CL A | Common | $94K | 0.0%Prev: 0.0% | 300 SH | Increased |
| Alphabet Inc-Cl C | Common | $28.7M | 13.3%Prev: 11.0% | 91,420 SH | Increased-20,800 SH |
| Amazon.com Inc. | Common | $69K | 0.0%Prev: 0.0% | 300 SH | Increased |
| Apollo Global Management, Inc. | Common | $32.6M | 15.1%Prev: 12.1% | 225,000 SH | Increased |
| Apple Inc. | Common | $678K | 0.3%Prev: 0.3% | 2,494 SH | Increased |
| Arcellx Inc | Common | $1.7M | 0.8%Prev: 0.9% | 25,700 SH | Decreased |
| Arcus Biosciences, Inc. | Common | $2.9M | 1.3%Prev: 0.5% | 121,241 SH | Increased+26,041 SH |
| AtriCure, Inc. | Common | $2.0M | 0.9%Prev: 0.7% | 51,400 SH | Increased+3,400 SH |
| Biogen Inc. | Common | $1.1M | 0.5%Prev: 0.1% | 6,000 SH | Increased+4,000 SH |
| Biohaven LTD | Common | $1.3M | 0.6% | 110,720 SH | New |
| Blackstone Group LP | Common | $32K | 0.0%Prev: 0.0% | 210 SH | Decreased |
| Bridgebio Pharma, Inc. | Common | $6.5M | 3.0%Prev: 1.8% | 85,000 SH | Increased |
| Bristol-Myers Squibb Company | Common | $1.2M | 0.5%Prev: 0.5% | 22,000 SH | Decreased-5,000 SH |
| Broadcom, Inc. | Common | $246K | 0.1%Prev: 0.1% | 710 SH | Increased |
| Calumet, Inc. | Common | $44.0M | 20.4%Prev: 20.8% | 2,214,969 SH | Decreased-610,262 SH |
| Canadian Natural Resources Limited | Common | $569K | 0.3%Prev: 0.2% | 16,800 SH | Increased |
| Catalyst Pharmaceuticals, Inc. | Common | $4.4M | 2.0%Prev: 1.5% | 189,000 SH | Increased |
| Centessa Pharmaceuticals PLC | Common | $100K | 0.0% | 4,000 SH | New |
| Cogent Biosciences Inc. | Common | $3.6M | 1.7% | 102,000 SH | New |
| Connect Biopharma Holdings Limited | Common | $564K | 0.3% | 200,000 SH | New |
| Corteva, Inc. | Common | $81K | 0.0%Prev: 0.3% | 1,206 SH | Decreased-9,845 SH |
| Cybin Inc | Common | $2.3M | 1.1%Prev: 0.3% | 285,182 SH | Increased+144,940 SH |
| Cytokinetics, Incorporated | Common | $2.2M | 1.0%Prev: 0.7% | 34,000 SH | Increased+4,000 SH |
| Danaher Corporation | Common | $41K | 0.0%Prev: 0.0% | 180 SH | Increased |
| Day One Biopharmaceuticals, Inc. | Common | $241K | 0.1%Prev: 0.4% | 25,884 SH | Decreased-104,616 SH |
| DocGo, Inc. | Common | $2.3M | 1.1%Prev: 1.7% | 2,670,850 SH | Decreased-400,000 SH |
| Dow Inc. | Common | $28K | 0.0%Prev: 0.0% | 1,206 SH | Increased |
| DuPont de Nemours, Inc. | Common | $151K | 0.1%Prev: 0.3% | 3,767 SH | Decreased-5,651 SH |
| Eastern Bankshares Inc | Common | $92K | 0.0%Prev: 0.0% | 5,000 SH | Increased |
| Evolus, Inc. | Common | $661K | 0.3% | 99,338 SH | New |
| Fate Therapeutics, Inc. | Common | $359K | 0.2%Prev: 0.2% | 365,000 SH | Decreased |
| FS KKR Capital Corp. | Common | $43K | 0.0%Prev: 0.0% | 2,875 SH | Decreased |
| GE HealthCare Technologies Inc | Common | $4K | 0.0%Prev: 0.0% | 50 SH | Increased |
| International Business Machines | Common | $634K | 0.3%Prev: 0.2% | 2,142 SH | Increased |
| International Game Technology PLC | Common | $39K | 0.0% | 2,500 SH | New |
| Invivyd, Inc. | Common | $247K | 0.1%Prev: 0.0% | 100,000 SH | Increased |
| iShares Biotechnology ETF | Common | $928K | 0.4%Prev: 0.3% | 5,500 SH | Increased+1,000 SH |
| iShares Russell Mid-Cap Growth | Common | $95K | 0.0%Prev: 0.0% | 695 SH | Decreased |
| Janus Henderson AAA CLO ETF | Common | $4.7M | 2.2%Prev: 9.0% | 93,528 SH | Decreased-344,226 SH |
| Jasper Therapeutics, Inc. | Common | $332K | 0.2%Prev: 0.2% | 181,389 SH | Decreased+10,000 SH |
| Johnson & Johnson | Common | $1.4M | 0.7%Prev: 0.5% | 6,922 SH | Increased |
| JPMorgan Chase & Co. | Common | $6.3M | 2.9%Prev: 2.6% | 19,477 SH | Decreased-897 SH |
| Kimberly-Clark Corporation | Common | $242K | 0.1%Prev: 0.3% | 2,400 SH | Decreased-3,600 SH |
| Kura Oncology, Inc. | Common | $407K | 0.2%Prev: 0.2% | 39,209 SH | Decreased-28,093 SH |
| Kyndryl Holdings Inc. | Common | $11K | 0.0%Prev: 0.0% | 428 SH | Decreased |
| Legacy Housing Corporation | Common | $78K | 0.0%Prev: 0.0% | 4,000 SH | Decreased |
| LENZ Therapeutics, Inc. | Common | $860K | 0.4%Prev: 1.5% | 53,732 SH | Decreased-28,268 SH |
| Madrigal Pharmaaceuticals, Inc. | Common | $1.2M | 0.5%Prev: 0.4% | 2,000 SH | Increased |
| Mereo BioPharm Group PLC | Common | $125K | 0.1%Prev: 0.2% | 300,337 SH | Decreased |
| Mersana Therapeutics, Inc. | Common | $289K | 0.1% | 10,000 SH | New |
| Microsoft Corporation | Common | $774K | 0.4%Prev: 0.3% | 1,600 SH | Decreased |
| Mondelez International Inc. | Common | $161K | 0.1%Prev: 0.2% | 3,000 SH | Decreased-5,000 SH |
| Nektar Therapeutics | Common | $655K | 0.3% | 15,500 SH | New |
| Nvidia Corp | Common | $239K | 0.1%Prev: 0.1% | 1,280 SH | Decreased |
| Occidental Petroleum Corporation | Common | $19K | 0.0%Prev: 0.0% | 469 SH | Decreased |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4K | 0.0%Prev: 0.0% | 194 SH | |
| Orchestra Biomed Holdings, Inc. | Common | $1.0M | 0.5%Prev: 0.2% | 250,000 SH | Increased+55,000 SH |
| Pelthos Therapeutics, Inc. | Common | $598K | 0.3%Prev: 0.1% | 19,281 SH | Increased+13,169 SH |
| Pfizer Inc. | Common | $805K | 0.4%Prev: 0.8% | 32,337 SH | Decreased-42,200 SH |
| Protagonist Therapeutics, Inc | Common | $6.4M | 3.0%Prev: 2.2% | 73,000 SH | Increased-10,000 SH |
| Quanta Services, Inc. | Common | $74K | 0.0%Prev: 0.0% | 176 SH | Increased |
| Rain Enhancement Technologies Holdco Inc | Common | $148K | 0.1% | 101,686 SH | New |
| Rezolute, Inc. | Common | $802K | 0.4%Prev: 1.0% | 340,000 SH | Decreased+65,000 SH |
| Ryman Hospitality Properties, Inc. | Common | $227K | 0.1%Prev: 0.4% | 2,400 SH | Decreased-9,600 SH |
| Salesforce, Inc. | Common | $20K | 0.0%Prev: 0.0% | 77 SH | Increased |
| Scholar Rock Holding Corporation | Common | $613K | 0.3%Prev: 0.1% | 13,913 SH | Increased+4,913 SH |
| Solid Bioscience Inc. | Common | $916K | 0.4%Prev: 0.4% | 162,440 SH | Decreased |
| SPDR S&P Biotech ETF | Common | $1.6M | 0.7%Prev: 0.2% | 13,000 SH | Increased+8,000 SH |
| Starwood Property Trust, Inc. | Common | $7K | 0.0% | 400 SH | New |
| Syndax Pharmaceutical, Inc. | Common | $8.7M | 4.0%Prev: 2.7% | 415,000 SH | Increased-13,000 SH |
| Tectonic Therapeutic, Inc. | Common | $1.5M | 0.7%Prev: 0.5% | 74,000 SH | Increased |
| TG Therapeutics, Inc. | Common | $1.3M | 0.6% | 45,000 SH | New |
| The Panagram BBB-B CLO ETF | Common | $1.3M | 0.6% | 47,807 SH | New |
| Thermo Fisher Scientific, Inc. | Common | $26K | 0.0%Prev: 0.0% | 45 SH | Increased |
| Travere Therapeutics, Inc. | Common | $7.1M | 3.3%Prev: 2.5% | 186,000 SH | Increased-74,000 SH |
| Ultragenyx Pharmaceutical Inc. | Common | $460K | 0.2%Prev: 0.6% | 20,006 SH | Decreased-31,994 SH |
| uniQure N.V. | Common | $96K | 0.0%Prev: 0.0% | 4,000 SH | Decreased+2,000 SH |
| United Healthcare Corp. | Common | $19K | 0.0%Prev: 0.0% | 57 SH | Decreased |
| United Rental, Inc. | Common | $63K | 0.0%Prev: 0.0% | 78 SH | Decreased |
| Vera Therapeutics, Inc. | Common | $1.3M | 0.6%Prev: 0.3% | 26,000 SH | Increased |
| Viridian Therapeutics, Inc. | Common | $4.5M | 2.1%Prev: 1.0% | 145,000 SH | Increased+28,426 SH |
| Wabtec Corporation | Common | $1K | 0.0%Prev: 0.0% | 6 SH | Increased |
| Wave Life Science Ltd. | Common | $1.5M | 0.7%Prev: 0.3% | 90,000 SH | Increased |
| Xenon Pharmaceuticals Inc. | Common | $491K | 0.2%Prev: 0.2% | 10,962 SH | Increased |
| Xeris Biopharma Holdings, Inc. | Common | $7.6M | 3.5%Prev: 3.3% | 970,000 SH | Decreased-45,000 SH |